You are here

Gladstone Foundation

 

In 2011, the Gladstone Foundation was established as a not-for-profit organization supporting the Gladstone Institutes. Led by Board Chair William H. Younger, Jr. and Vice Chair Stasia Obremskey, the Board of Directors comprises unsurpassed leaders who understand that the search for cures must begin with deep biological knowledge. These dedicated volunteers know that life science research will provide solutions for major unsolved diseases of the brain, the heart, and the immune system, ultimately enabling society to address health-related humanitarian issues worldwide.


Gladstone Foundation Board of Directors

WILLIAM H. YOUNGER, JR (CHAIR)
Managing Director, Sutter Hill Ventures

STASIA A. OBREMSKEY (VICE CHAIR)
Strategy Director, Contraceptive Technology Development, Rhia Ventures 

CHRIS BOSKIN
Media Consultant

MARIANNE DE BACKER, PHD
Head of Pharmaceuticals Business Development & Licensing,
Bayer

PAUL C. EDWARDS
Edwards Partners

TOM FURST
Former CFO, SRI International

LINDA GRAIS, MD, JD
Former President and CEO, Ocera Therapeutics

PERRY KARSEN
Former CEO, Celgene Cellular Therapeutics and
EVP, Chief Operations Officer of Celgene Corporation

LAURA S. LEHMAN, PHD
Vice President, Research Strategy and Portfolio Management, Gilead Sciences

GARY MORGENTHALER
Partner, Morgenthaler Ventures

STEVE RICHARDSON
Co-Chief Executive Officer, Alexandria Real Estate Equitites, Inc. 

DOUGLAS G. SCRIVNER
Retired General Counsel, Accenture

DEEPAK SRIVASTAVA, MD
President, Gladstone Institutes
Director, Roddenberry Stem Cell Center

GARY T. STEELE
Retired Chairman, President, and CEO, Landec

JAMES B. TANANBAUM, MD
Founder, CEO, and Managing Director, Foresite Capital Management

R. SANDERS WILLIAMS, MD
President Emeritus, Gladstone Institutes

CLARK WINSLOW
Founder, Winslow Capital Management